Luye Pharma Group's market cap is currently $13.28B. The company's EPS TTM is HK$0.09073259457; its P/E ratio is 29.58; Luye Pharma Group is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$0.09. See an overview of income statement, balance sheet, and cash flow financials.
